Merck (MRK) Stock Jumps 4% on Positive Trial Data
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Merck took a big gamble in buying a therapeutic as part of an acquisition deal and it appears to have paid off, sending MRK stock soaring.
The post Merck (MRK) Stock Jumps 4% on Positive Trial Data appeared first on InvestorPlace.
More From InvestorPlace